These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2594683)

  • 1. Quantitative whole-body autoradiographic determination of tacrine tissue distribution in rats following intravenous or oral dose.
    McNally W; Roth M; Young R; Bockbrader H; Chang T
    Pharm Res; 1989 Nov; 6(11):924-30. PubMed ID: 2594683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of tacrine and metabolites in rat brain and plasma after single- and multiple-dose regimens. Evidence for accumulation of tacrine in brain tissue.
    McNally WP; Pool WF; Sinz MW; Dehart P; Ortwine DF; Huang CC; Chang T; Woolf TF
    Drug Metab Dispos; 1996 Jun; 24(6):628-33. PubMed ID: 8781777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
    Forsyth DR; Wilcock GK; Morgan RA; Truman CA; Ford JM; Roberts CJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):634-41. PubMed ID: 2598567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease.
    Drukarch B; Leysen JE; Stoof JC
    Life Sci; 1988; 42(9):1011-7. PubMed ID: 2893967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose-to-brain delivery of tacrine.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine.
    Hartvig P; Askmark H; Aquilonius SM; Wiklund L; Lindström B
    Eur J Clin Pharmacol; 1990; 38(3):259-63. PubMed ID: 2340845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated administration of tacrine to normal rats: effects on cholinergic, glutamatergic, and GABAergic receptor subtypes in rat brain using receptor autoradiography.
    Sihver W; Günther P; Schliebs R; Bigl V
    Neurochem Int; 1997 Nov; 31(5):693-703. PubMed ID: 9364455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography study of [11C]methyl-tetrahydroaminoacridine (methyl-tacrine) in baboon brain.
    Tavitian B; Pappata S; Bonnot-Lours S; Prenant C; Jobert A; Crouzel C; Di Giamberardino L
    Eur J Pharmacol; 1993 May; 236(2):229-38. PubMed ID: 8319751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term oral administration of memory-enhancing doses of tacrine in mice: a study of potential toxicity and side effects.
    Fitten LJ; Flood JF; Baxter CF; Tachiki KH; Perryman K
    J Gerontol; 1987 Nov; 42(6):681-5. PubMed ID: 3680887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes.
    Nielsen JA; Mena EE; Williams IH; Nocerini MR; Liston D
    Eur J Pharmacol; 1989 Nov; 173(1):53-64. PubMed ID: 2606156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for increased bioavailability of tacrine in fasted rats.
    Sung JH; Hong SS; Ahn SH; Li H; Seo SY; Park CH; Park BS; Chung SJ
    J Pharm Pharmacol; 2006 May; 58(5):643-9. PubMed ID: 16640833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
    Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrine and its 7-methoxy derivate; time-change concentration in plasma and brain tissue and basic toxicological profile in rats.
    Zdarova Karasova J; Soukup O; Korabecny J; Hroch M; Krejciova M; Hrabinova M; Misik J; Novotny L; Hepnarova V; Kuca K
    Drug Chem Toxicol; 2021 Mar; 44(2):207-214. PubMed ID: 31257938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.
    Wagstaff AJ; McTavish D
    Drugs Aging; 1994 Jun; 4(6):510-40. PubMed ID: 7521234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.
    Goh CW; Aw CC; Lee JH; Chen CP; Browne ER
    Drug Metab Dispos; 2011 Mar; 39(3):402-11. PubMed ID: 21148081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
    Jann MW; Shirley KL; Small GW
    Clin Pharmacokinet; 2002; 41(10):719-39. PubMed ID: 12162759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    Alzheimer Dis Assoc Disord; 2008; 22(2):116-24. PubMed ID: 18525282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of tacrine.
    Madden S; Spaldin V; Park BK
    Clin Pharmacokinet; 1995 Jun; 28(6):449-57. PubMed ID: 7656503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 1999 Sep; 380(2-3):101-7. PubMed ID: 10513568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.